The present invention provides a composition for treating ischemic diseases or neurogenic inflammatory disorders containing a secretome of neural progenitor cells (NPCs) as an active ingredient. The secretome of NPCs of the present invention reduces an ischemic injury site and enables neurological functions to recov...

The present invention relates to a method for isolating dopamine neurons and a pharmaceutical composition for treating Parkinson"s disease, containing dopamine neurons isolated using same. The method for isolating dopamine neurons comprises a step for isolating trophoblast glycoprotein (TPBG)-positive dopamine neuro...

The present invention relates to a method for inducing differentiation into dopamine neuronal precursor cells from stem cells and a mass production method for dopamine neuronal precursor cells. When using the method of the present invention, stem cells can be efficiently differentiated into neuronal precursor cells,...

The present invention relates to a method for differentiating a spherical neural mass (SNM) into retinal outer layer cells, and a composition containing the retinal outer layer cells prepared by the differentiation method. If the differentiation method of the present invention is used, the SNM can be efficiently dif...

The present invention relates to a pharmaceutical composition for treating degenerative brain disease, comprising neural precursor cells derived from pluripotent stem cells, and, according to one embodiment, neural precursor cells differentiated from pluripotent stem cells and administered by intracerebroventricular...

The invention relates to a process for producing a freeze-dried composition comprising a non-pathogenic C. acnes strain, the obtained freeze-dried composition, topical compositions comprising said freeze-dried compositions as well as the use thereof for treating or preventing acne in a human subject. ...